PCOLCE and Hepatic fibrosis: In two additional models involving systemic PCPE-1 suppression, i.e., a systemic Pcolce KO model and PCPE-1-targeted peptide vaccine model, generated to test a therapeutic proof of concept, it was shown that both models were associated with diminished liver fibrosis.